Dion Weerasuriya

Trainee Advanced Therapy Scientist at Advent Bioservices
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
UK
Languages
  • French Elementary proficiency
  • German Elementary proficiency
  • English Native or bilingual proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Advanced Therapeutic Medicinal Products
    NSF - Health Sciences
    Oct, 2022
    - Nov, 2024
  • Advanced Cell Therapy Technology
    Cytiva
    May, 2022
    - Nov, 2024
  • Good Manufacturing Practice (GMP) - RSC Approved
    Reading Scientific Services Ltd (RSSL)
    Apr, 2022
    - Nov, 2024
  • Oracle Certified Expert Database SQL
    Udemy
    Sep, 2020
    - Nov, 2024
  • Home Office Licensee Training PIL AB
    Charles River Laboratories
    Jan, 2020
    - Nov, 2024
  • Strategic Business Management: Microeconomics
    Paul Merage School of Business, University of California Irvine
    Sep, 2018
    - Nov, 2024

Experience

    • United Kingdom
    • Biotechnology
    • 1 - 100 Employee
    • Trainee Advanced Therapy Scientist
      • Mar 2022 - Present

    • United Kingdom
    • Research Services
    • 700 & Above Employee
    • Honorary Researcher
      • Jan 2020 - Mar 2021

      Conducted an optogenetic study to identify the anti-epileptic properties of a novel cellular candidate for restoring GABAergic inhibitory networks in the epileptic hippocampus, the neurogliaform (NGF) interneuron, in in vitro Temporal Lobe Epilepsy (TLE) models. Key techniques: optogenetics, patch clamp electrophysiology, python programming Conducted an optogenetic study to identify the anti-epileptic properties of a novel cellular candidate for restoring GABAergic inhibitory networks in the epileptic hippocampus, the neurogliaform (NGF) interneuron, in in vitro Temporal Lobe Epilepsy (TLE) models. Key techniques: optogenetics, patch clamp electrophysiology, python programming

    • United Kingdom
    • E-Learning Providers
    • 300 - 400 Employee
    • Mathematics Tutor
      • Jul 2017 - Jan 2020

      Conducted individual and group mathematics classes for key-stage 3 pupils and those preparing for GCSEs and A-Levels (Edexcel, AQA and Cambridge qualifications). In this role I played an active role in the academic development of pupils to achieve a 100% pass rate with many securing A* and A grades (numerical grades 9, 8 and 7 at GCSE level) Conducted individual and group mathematics classes for key-stage 3 pupils and those preparing for GCSEs and A-Levels (Edexcel, AQA and Cambridge qualifications). In this role I played an active role in the academic development of pupils to achieve a 100% pass rate with many securing A* and A grades (numerical grades 9, 8 and 7 at GCSE level)

    • United Kingdom
    • Research Services
    • 700 & Above Employee
    • Research Intern
      • Jul 2019 - Sep 2019

      Assessed the role of perturbed TDP-43 autoregulation in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia (ALS-FTD) pathogenesis Key techniques: Site-directed mutagenesis, neuronal cell culture, cell fractionation, western blotting Assessed the role of perturbed TDP-43 autoregulation in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia (ALS-FTD) pathogenesis Key techniques: Site-directed mutagenesis, neuronal cell culture, cell fractionation, western blotting

    • Research Services
    • 700 & Above Employee
    • Undergraduate Researcher
      • Jan 2019 - Aug 2019

      Utilised a chemogenetic approach to successfully map the excitatory (glutamatergic) and inhibitory (GABAergic) neuronal projections from the brainstem oral mesopontine reticular formation (PnO) to key regions involved in mammalian sleep-wakefulness control including the Ventral Tegmental Area, Preoptic Area and Lateral Hypothalamus. The results of this in vitro project will be further used in the identification of novel targets for sedatives and anaesthetics, providing a deeper understanding of how these drugs may modulate network activity at the cellular and network levels.

    • France
    • Research Services
    • 700 & Above Employee
    • Scientific Research Assistant
      • Jun 2018 - Sep 2018

      Studied a potential therapeutic approach to Dominant Optic Atrophy (DOA), a rare form of neuropathic blindness (in vitro and in vivo models). My work aimed to identify how the X protein of the Borna Disease Virus (BDV) can elicit neuroprotective mechanisms during DOA in the context of retinal ganglion cell and optic nerve degeneration as a result of mutations in the OPA1 gene encoding a key mitochondrial fusion protein. Areas of focus: perturbations in mitochondrial fusion/fission dynamics and their influence on neuronal homeostasis (optic nerve) during DOA, synaptic plasticity, axonal regeneration, neuroprotection, retinal degeneration and cortical integrity. Key tasks undertaken: genotyping, neuronal cell culture, cryosectioning, immunohistochemistry, western blotting, protein/cell quantification, statistical analysis.

Education

  • Imperial College London
    Bachelor of Science - BSc (Hons) ARCS, Biological Sciences
    2016 - 2019
  • UCL Queen Square Institute of Neurology
    Master of Science - MSc, Clinical Neuroscience
    2019 - 2020

Community

You need to have a working account to view this content. Click here to join now